BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16333082)

  • 1. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
    Pickering JW; Sant HW; Bowles CA; Roberts WL; Woods GL
    J Clin Microbiol; 2005 Dec; 43(12):5957-62. PubMed ID: 16333082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
    Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
    J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
    Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
    Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
    Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
    J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
    Zeng SY; Liu T; Meng WT; Chen YN
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of plasma (1-->3) beta-D-glucan concentrations in birds naturally and experimentally infected with aspergillus fumigatus.
    Burco JD; Ziccardi MH; Clemons KV; Tell LA
    Avian Dis; 2012 Mar; 56(1):183-91. PubMed ID: 22545545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histoplasmosis as a cause for a positive Fungitell (1 --> 3)-beta-D-glucan test.
    Egan L; Connolly P; Wheat LJ; Fuller D; Dais TE; Knox KS; Hage CA
    Med Mycol; 2008 Feb; 46(1):93-5. PubMed ID: 18297546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.
    Ahmad S; Khan ZU; Theyyathel AM
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):165-71. PubMed ID: 17574786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.
    Sarwar M; Gardezi SAH; Zaman G; Ikram A; Satti L; Khadim MT
    J Pak Med Assoc; 2020 Mar; 70(3):442-446. PubMed ID: 32207422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections.
    Mori T; Ikemoto H; Matsumura M; Yoshida M; Inada K; Endo S; Ito A; Watanabe S; Yamaguchi H; Mitsuya M; Kodama M; Tani T; Yokota T; Kobayashi T; Kambayashi J; Nakamura T; Masaoka T; Teshima H; Yoshinaga T; Kohno S; Hara K; Miyazaki S
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):553-60. PubMed ID: 9263735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of histoplasmosis in immunosuppressed patients.
    Kauffman CA
    Curr Opin Infect Dis; 2008 Aug; 21(4):421-5. PubMed ID: 18594296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
    Metan G; Ağkuş C; Buldu H; Koç AN
    Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients].
    Jarque I; Andreu R; Salavert M; Gómez D; Pemán J; Gobernado M; Sanz MA
    Rev Iberoam Micol; 2003 Sep; 20(3):116-8. PubMed ID: 15456368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an Intensive Care Unit: a case report.
    Saito T; Shime N; Itoh K; Fujita N; Saito Y; Shinozaki M; Shibuya K; Makimura K; Hashimoto S
    Infection; 2009 Dec; 37(6):547-50. PubMed ID: 19730788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis].
    Moragues MD; Amutio E; García-Ruiz JC; Pontón J
    Rev Iberoam Micol; 2003 Sep; 20(3):103-10. PubMed ID: 15456366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Odabasi Z; Mattiuzzi G; Estey E; Kantarjian H; Saeki F; Ridge RJ; Ketchum PA; Finkelman MA; Rex JH; Ostrosky-Zeichner L
    Clin Infect Dis; 2004 Jul; 39(2):199-205. PubMed ID: 15307029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
    Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.